| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 2.24e-05 | 15 | 75 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 9.73e-05 | 24 | 75 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 1.10e-04 | 25 | 75 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 5.26e-04 | 42 | 75 | 3 | GO:0098918 | |
| GeneOntologyBiologicalProcess | CRD-mediated mRNA stabilization | 7.46e-06 | 11 | 75 | 3 | GO:0070934 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 4.67e-05 | 178 | 75 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 6.24e-05 | 115 | 75 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.39e-04 | 217 | 75 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.78e-04 | 77 | 75 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.86e-04 | 145 | 75 | 5 | GO:0051028 | |
| GeneOntologyBiologicalProcess | neuron projection development | WHRN IGF2BP1 NRXN3 ERCC6 CELSR3 NRDC MTR ALS2 HERC1 THOC2 RIMS2 SHANK3 HNRNPK NRP1 | 1.93e-04 | 1285 | 75 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | ketone body biosynthetic process | 1.94e-04 | 6 | 75 | 2 | GO:0046951 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome, telomeric region | 2.12e-04 | 32 | 75 | 3 | GO:0070198 | |
| GeneOntologyBiologicalProcess | folic acid-containing compound metabolic process | 2.55e-04 | 34 | 75 | 3 | GO:0006760 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.86e-04 | 87 | 75 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 2.98e-04 | 88 | 75 | 4 | GO:0043489 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 5.54e-05 | 269 | 76 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 8.32e-05 | 287 | 76 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | LUC7L GTF2F2 ERCC6 ATR BRCA2 INTS7 NUP210L SUPT5H FANCI TNKS PPIH THOC2 SNRPG HNRNPK | 3.94e-04 | 1377 | 76 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 4.16e-04 | 96 | 76 | 4 | GO:0010494 | |
| GeneOntologyCellularComponent | P-body | 5.24e-04 | 102 | 76 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MPP2 NRXN3 CELSR3 PRSS12 NXPH1 ALS2 RIMS2 SHANK3 HNRNPK NRP1 | 7.28e-04 | 817 | 76 | 10 | GO:0098978 |
| MousePheno | abnormal motor learning | 7.72e-06 | 60 | 64 | 5 | MP:0002804 | |
| Domain | KH_1 | 4.41e-07 | 38 | 76 | 5 | PF00013 | |
| Domain | - | 5.05e-07 | 39 | 76 | 5 | 3.30.1370.10 | |
| Domain | KH | 5.75e-07 | 40 | 76 | 5 | SM00322 | |
| Domain | KH_dom | 5.75e-07 | 40 | 76 | 5 | IPR004087 | |
| Domain | Laminin_G_2 | 5.75e-07 | 40 | 76 | 5 | PF02210 | |
| Domain | KH_TYPE_1 | 7.38e-07 | 42 | 76 | 5 | PS50084 | |
| Domain | KH_dom_type_1 | 9.37e-07 | 44 | 76 | 5 | IPR004088 | |
| Domain | LamG | 9.37e-07 | 44 | 76 | 5 | SM00282 | |
| Domain | Laminin_G | 3.78e-06 | 58 | 76 | 5 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 1.68e-05 | 38 | 76 | 4 | PS50025 | |
| Domain | ConA-like_dom | 3.05e-05 | 219 | 76 | 7 | IPR013320 | |
| Domain | EGF_3 | 4.77e-05 | 235 | 76 | 7 | PS50026 | |
| Domain | EGF | 4.77e-05 | 235 | 76 | 7 | SM00181 | |
| Domain | EGF-like_dom | 6.88e-05 | 249 | 76 | 7 | IPR000742 | |
| Domain | EGF_1 | 7.98e-05 | 255 | 76 | 7 | PS00022 | |
| Domain | FA58C | 8.17e-05 | 21 | 76 | 3 | SM00231 | |
| Domain | FA58C_3 | 8.17e-05 | 21 | 76 | 3 | PS50022 | |
| Domain | FA58C_1 | 8.17e-05 | 21 | 76 | 3 | PS01285 | |
| Domain | FA58C_2 | 8.17e-05 | 21 | 76 | 3 | PS01286 | |
| Domain | EGF_2 | 1.01e-04 | 265 | 76 | 7 | PS01186 | |
| Domain | F5_F8_type_C | 1.23e-04 | 24 | 76 | 3 | PF00754 | |
| Domain | FA58C | 1.23e-04 | 24 | 76 | 3 | IPR000421 | |
| Domain | EGF | 1.63e-04 | 126 | 76 | 5 | PF00008 | |
| Domain | PDZ | 2.74e-04 | 141 | 76 | 5 | PF00595 | |
| Domain | AAA+_ATPase | 3.02e-04 | 144 | 76 | 5 | IPR003593 | |
| Domain | AAA | 3.02e-04 | 144 | 76 | 5 | SM00382 | |
| Domain | PDZ | 3.43e-04 | 148 | 76 | 5 | SM00228 | |
| Domain | - | 3.65e-04 | 150 | 76 | 5 | 2.30.42.10 | |
| Domain | PDZ | 3.76e-04 | 151 | 76 | 5 | PS50106 | |
| Domain | PDZ | 3.88e-04 | 152 | 76 | 5 | IPR001478 | |
| Domain | Galactose-bd-like | 5.85e-04 | 94 | 76 | 4 | IPR008979 | |
| Domain | - | 6.09e-04 | 95 | 76 | 4 | 2.60.120.200 | |
| Domain | - | 6.63e-04 | 42 | 76 | 3 | 3.20.20.70 | |
| Domain | EGF-like_CS | 6.79e-04 | 261 | 76 | 6 | IPR013032 | |
| Domain | L27_C | 7.20e-04 | 10 | 76 | 2 | IPR014775 | |
| Domain | L27 | 7.20e-04 | 10 | 76 | 2 | PF02828 | |
| Domain | Ank_3 | 7.20e-04 | 10 | 76 | 2 | PF13606 | |
| Domain | ASX_HYDROXYL | 7.39e-04 | 100 | 76 | 4 | PS00010 | |
| Domain | Aldolase_TIM | 7.61e-04 | 44 | 76 | 3 | IPR013785 | |
| Domain | - | 8.57e-04 | 746 | 76 | 10 | 3.40.50.300 | |
| Domain | - | 8.78e-04 | 11 | 76 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 8.78e-04 | 11 | 76 | 2 | IPR023413 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.19e-04 | 106 | 76 | 4 | IPR000152 | |
| Domain | EGF_3 | 1.05e-03 | 12 | 76 | 2 | PF12947 | |
| Domain | EGF_dom | 1.05e-03 | 12 | 76 | 2 | IPR024731 | |
| Domain | L27 | 1.24e-03 | 13 | 76 | 2 | SM00569 | |
| Domain | L27 | 1.24e-03 | 13 | 76 | 2 | PS51022 | |
| Domain | L27_dom | 1.24e-03 | 13 | 76 | 2 | IPR004172 | |
| Domain | EGF_CA | 1.55e-03 | 122 | 76 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.64e-03 | 124 | 76 | 4 | IPR001881 | |
| Domain | Guanylate_kinase_CS | 1.89e-03 | 16 | 76 | 2 | IPR020590 | |
| Domain | P-loop_NTPase | 2.23e-03 | 848 | 76 | 10 | IPR027417 | |
| Domain | RCC1 | 2.96e-03 | 20 | 76 | 2 | PF00415 | |
| Domain | RCC1_1 | 3.26e-03 | 21 | 76 | 2 | PS00625 | |
| Domain | RCC1_2 | 3.26e-03 | 21 | 76 | 2 | PS00626 | |
| Domain | RCC1_3 | 3.26e-03 | 21 | 76 | 2 | PS50012 | |
| Domain | - | 3.28e-03 | 73 | 76 | 3 | 2.60.120.260 | |
| Domain | Reg_chr_condens | 3.58e-03 | 22 | 76 | 2 | IPR000408 | |
| Domain | - | 3.58e-03 | 22 | 76 | 2 | 2.130.10.30 | |
| Domain | GUANYLATE_KINASE_2 | 3.91e-03 | 23 | 76 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 3.91e-03 | 23 | 76 | 2 | PS00856 | |
| Domain | RCC1/BLIP-II | 3.91e-03 | 23 | 76 | 2 | IPR009091 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 9.78e-05 | 62 | 55 | 4 | M27618 | |
| Pathway | WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK | 1.02e-04 | 120 | 55 | 5 | M40049 | |
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 2.39e-09 | 25 | 77 | 5 | 23563309 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20627640 | ||
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 1.04e-08 | 3 | 77 | 3 | 17296566 | |
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 1.04e-08 | 3 | 77 | 3 | 29476152 | |
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 1.04e-08 | 3 | 77 | 3 | 16049158 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 9891060 | ||
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 1.04e-08 | 3 | 77 | 3 | 15601260 | |
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 1.04e-08 | 3 | 77 | 3 | 32668274 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20080952 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 27184842 | ||
| Pubmed | H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. | 4.17e-08 | 4 | 77 | 3 | 10875929 | |
| Pubmed | mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. | 4.17e-08 | 4 | 77 | 3 | 21576258 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 15225648 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 26160756 | ||
| Pubmed | IMP2 axonal localization, RNA interactome, and function in the development of axon trajectories. | 4.17e-08 | 4 | 77 | 3 | 27385015 | |
| Pubmed | LUC7L IGF2BP1 IGF2BP3 IGF2BP2 CLPB FANCI MRPS11 RFC1 PPIH THOC2 SNRPG HNRNPK | 5.47e-08 | 713 | 77 | 12 | 29802200 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | LUC7L TDRKH IGF2BP1 IGF2BP3 IGF2BP2 CLPB VWA8 MTHFD1L SPTLC1 MRPS11 MTR NAV1 CCDC25 HERC1 ZZEF1 HNRNPK | 1.45e-07 | 1496 | 77 | 16 | 32877691 |
| Pubmed | 2.08e-07 | 6 | 77 | 3 | 33436560 | ||
| Pubmed | IGF2BP1 IGF2BP3 IGF2BP2 INTS7 MTHFD1L FANCI DDI2 PPIH THOC2 CA8 | 2.92e-07 | 534 | 77 | 10 | 35032548 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HBS1L IGF2BP1 IGF2R ATR NRDC CLPB SUPT5H MTHFD1L FANCI SPTLC1 MTR HMGCL RFC1 THOC2 HNRNPK | 4.62e-07 | 1425 | 77 | 15 | 30948266 |
| Pubmed | METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. | 8.68e-07 | 9 | 77 | 3 | 37340443 | |
| Pubmed | HBS1L IGF2BP1 IGF2BP3 IGF2BP2 NRDC CLPB SUPT5H MTHFD1L SPTLC1 MRPS11 RFC1 PPIH SBSN HNRNPK | 1.23e-06 | 1335 | 77 | 14 | 29229926 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | LUC7L HBS1L IGF2BP1 GTF2F2 IGF2BP3 NRDC VWA8 INTS7 MTHFD1L NAV1 RFC1 PPIH SNRPG HNRNPK | 2.43e-06 | 1415 | 77 | 14 | 28515276 |
| Pubmed | 2.49e-06 | 390 | 77 | 8 | 17643375 | ||
| Pubmed | 2.57e-06 | 43 | 77 | 4 | 36950384 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HBS1L GTF2F2 IGF2BP3 IMPDH1 NRDC SUPT5H FANCI MTR DDI2 UNC13D HERC1 ZZEF1 HNRNPK CHUK | 3.36e-06 | 1455 | 77 | 14 | 22863883 |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 31150793 | ||
| Pubmed | A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. | 4.84e-06 | 2 | 77 | 2 | 11713986 | |
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 19726068 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 26807827 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 12921532 | ||
| Pubmed | 4.84e-06 | 2 | 77 | 2 | 11992722 | ||
| Pubmed | RNA-binding IMPs promote cell adhesion and invadopodia formation. | 4.84e-06 | 2 | 77 | 2 | 16541107 | |
| Pubmed | IGF2BP3 BRCA2 CLPB VWA8 INTS7 NUP210L MTHFD1L SPTLC1 PPIH RIMS2 | 6.40e-06 | 754 | 77 | 10 | 35906200 | |
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 7.28e-06 | 120 | 77 | 5 | 37929963 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.24e-05 | 486 | 77 | 8 | 30940648 | |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 1.36e-05 | 65 | 77 | 4 | 27453043 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 24672057 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 29217458 | ||
| Pubmed | Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination. | 1.45e-05 | 3 | 77 | 2 | 34828369 | |
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 38701040 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 38572589 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 32134323 | ||
| Pubmed | 1.45e-05 | 3 | 77 | 2 | 28684355 | ||
| Pubmed | Mechanism of RAD51-dependent DNA interstrand cross-link repair. | 1.45e-05 | 3 | 77 | 2 | 21719678 | |
| Pubmed | An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis. | 1.45e-05 | 3 | 77 | 2 | 32245947 | |
| Pubmed | LUC7L IGF2BP1 IGF2BP3 IGF2BP2 CLPB VWA8 MTHFD1L FANCI SPTLC1 MRPS11 RFC1 THOC2 CHUK | 1.55e-05 | 1440 | 77 | 13 | 30833792 | |
| Pubmed | Exploring the link between MORF4L1 and risk of breast cancer. | 2.04e-05 | 24 | 77 | 3 | 21466675 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.40e-05 | 258 | 77 | 6 | 37794589 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | LUC7L IGF2BP1 IGF2BP3 IGF2BP2 VWA8 SUPT5H MRPS11 PPIH THOC2 SNRPG HNRNPK | 2.57e-05 | 1082 | 77 | 11 | 38697112 |
| Pubmed | PHKB HBS1L ZNF600 IGF2R NRDC DDI2 UNC13D ALS2 HERC1 THOC2 HNRNPK | 2.61e-05 | 1084 | 77 | 11 | 11544199 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 20513533 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 18273817 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 23670970 | ||
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 17151928 | ||
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 2.89e-05 | 4 | 77 | 2 | 23548269 | |
| Pubmed | FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. | 2.89e-05 | 4 | 77 | 2 | 18931676 | |
| Pubmed | 2.89e-05 | 4 | 77 | 2 | 19737859 | ||
| Pubmed | Same but different - Molecular comparison of human KTI12 and PSTK. | 2.94e-05 | 27 | 77 | 3 | 33417976 | |
| Pubmed | IGF2BP1 GTF2F2 IGF2BP3 IGF2BP2 FANCI RFC1 PPIH THOC2 SNRPG HNRNPK CCDC7 | 3.06e-05 | 1103 | 77 | 11 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOCAD HIVEP2 IGF2R IMPDH1 CELSR3 VWA8 MTHFD1L FANCI NAV1 HERC1 ZZEF1 | 3.11e-05 | 1105 | 77 | 11 | 35748872 |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | PHKB IMPDH1 ATR CLPB NUP210L SUPT5H MTHFD1L MRPS11 DDI2 PM20D2 | 3.90e-05 | 931 | 77 | 10 | 27432908 |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 3.92e-05 | 85 | 77 | 4 | 16051665 | |
| Pubmed | 4.18e-05 | 285 | 77 | 6 | 32838362 | ||
| Pubmed | 4.25e-05 | 173 | 77 | 5 | 23979707 | ||
| Pubmed | 4.30e-05 | 87 | 77 | 4 | 33711283 | ||
| Pubmed | LUC7L IGF2BP1 IGF2BP3 IGF2BP2 IMPDH1 CLPB VWA8 RFC1 PPIH THOC2 SBSN NRP1 | 4.61e-05 | 1371 | 77 | 12 | 36244648 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 37770450 | ||
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 18642075 | ||
| Pubmed | Cross-reactivity of anti-programmed death ligand 2 polyclonal antibody in mouse tissues. | 4.82e-05 | 5 | 77 | 2 | 23090063 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 18842997 | ||
| Pubmed | Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. | 4.82e-05 | 5 | 77 | 2 | 15199141 | |
| Pubmed | 4.82e-05 | 5 | 77 | 2 | 25843623 | ||
| Pubmed | A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. | 4.94e-05 | 32 | 77 | 3 | 24192035 | |
| Pubmed | 5.43e-05 | 33 | 77 | 3 | 19714462 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | IGF2BP1 IGF2BP2 NRDC CLPB SUPT5H MTHFD1L FANCI TNKS SBSN HNRNPK | 5.69e-05 | 974 | 77 | 10 | 28675297 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.87e-05 | 605 | 77 | 8 | 28977666 | |
| Pubmed | A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. | 6.07e-05 | 95 | 77 | 4 | 37211047 | |
| Pubmed | 6.58e-05 | 615 | 77 | 8 | 31048545 | ||
| Pubmed | 7.07e-05 | 36 | 77 | 3 | 17289661 | ||
| Pubmed | Tracing the genetic footprints of vertebrate landing in non-teleost ray-finned fishes. | 7.22e-05 | 6 | 77 | 2 | 33545088 | |
| Pubmed | ATR-ATRIP kinase complex triggers activation of the Fanconi anemia DNA repair pathway. | 7.22e-05 | 6 | 77 | 2 | 22258451 | |
| Pubmed | Decoding Mammalian Ribosome-mRNA States by Translational GTPase Complexes. | 7.22e-05 | 6 | 77 | 2 | 27863242 | |
| Pubmed | Molecular cloning and characterization of Pals, proteins associated with mLin-7. | 7.22e-05 | 6 | 77 | 2 | 10753959 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 7.22e-05 | 6 | 77 | 2 | 34143959 | |
| Pubmed | 7.22e-05 | 6 | 77 | 2 | 1322799 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.38e-05 | 1005 | 77 | 10 | 19615732 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 7.53e-05 | 462 | 77 | 7 | 31138677 | |
| Pubmed | A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. | 7.68e-05 | 37 | 77 | 3 | 19116388 | |
| Pubmed | 8.01e-05 | 102 | 77 | 4 | 26584622 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | IGF2BP1 IGF2BP3 CLPB MTHFD1L FANCI SPTLC1 MTR RFC1 PPIH THOC2 HNRNPK | 9.88e-05 | 1257 | 77 | 11 | 37317656 |
| Pubmed | 9.97e-05 | 653 | 77 | 8 | 22586326 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 19626602 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 18447718 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 16485136 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 9856994 | ||
| Pubmed | 1.01e-04 | 7 | 77 | 2 | 20306497 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.11e-04 | 212 | 77 | 5 | 33853758 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | LUC7L IGF2BP1 IGF2BP3 IGF2BP2 MTHFD1L FANCI SPTLC1 MTR ALS2 HERC1 SNRPG | 1.19e-04 | 1284 | 77 | 11 | 17353931 |
| Pubmed | FOCAD NELL1 HIVEP2 CELSR3 CLPB SUPT5H TNKS ZNF350 PALS2 HNRNPK CHUK | 1.20e-04 | 1285 | 77 | 11 | 35914814 | |
| Interaction | MRPS27 interactions | 3.63e-05 | 333 | 76 | 8 | int:MRPS27 | |
| Interaction | HELQ interactions | 5.61e-05 | 20 | 76 | 3 | int:HELQ | |
| Interaction | CIT interactions | LUC7L HBS1L IGF2BP1 IGF2BP3 IGF2BP2 CLPB VWA8 SUPT5H FANCI CCDC25 HERC1 PPIH THOC2 ZZEF1 SHANK3 HNRNPK | 8.30e-05 | 1450 | 76 | 16 | int:CIT |
| Interaction | UCN3 interactions | 8.65e-05 | 23 | 76 | 3 | int:UCN3 | |
| Interaction | MRPS22 interactions | 9.14e-05 | 281 | 76 | 7 | int:MRPS22 | |
| Interaction | MRPS9 interactions | 9.49e-05 | 382 | 76 | 8 | int:MRPS9 | |
| Interaction | NXPH1 interactions | 1.12e-04 | 25 | 76 | 3 | int:NXPH1 | |
| Interaction | SNX32 interactions | 1.12e-04 | 25 | 76 | 3 | int:SNX32 | |
| Interaction | MIR138-1 interactions | 1.27e-04 | 68 | 76 | 4 | int:MIR138-1 | |
| Interaction | MIR9-3 interactions | 1.42e-04 | 70 | 76 | 4 | int:MIR9-3 | |
| Interaction | MIR140 interactions | 1.50e-04 | 71 | 76 | 4 | int:MIR140 | |
| Interaction | MIR122 interactions | 1.50e-04 | 71 | 76 | 4 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 1.50e-04 | 71 | 76 | 4 | int:MIR29B2 | |
| Interaction | METTL17 interactions | 1.57e-04 | 411 | 76 | 8 | int:METTL17 | |
| Interaction | MIR18A interactions | 1.67e-04 | 73 | 76 | 4 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 1.67e-04 | 73 | 76 | 4 | int:MIR29B1 | |
| Interaction | MIR15A interactions | 1.85e-04 | 75 | 76 | 4 | int:MIR15A | |
| Interaction | MRPS34 interactions | 1.93e-04 | 317 | 76 | 7 | int:MRPS34 | |
| Interaction | MIR7-3 interactions | 1.95e-04 | 76 | 76 | 4 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 1.95e-04 | 76 | 76 | 4 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 1.95e-04 | 76 | 76 | 4 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 1.95e-04 | 76 | 76 | 4 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 2.05e-04 | 77 | 76 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 2.05e-04 | 77 | 76 | 4 | int:MIR200A | |
| Interaction | MRPS5 interactions | 2.08e-04 | 321 | 76 | 7 | int:MRPS5 | |
| Interaction | MIR92A1 interactions | 2.16e-04 | 78 | 76 | 4 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 2.16e-04 | 78 | 76 | 4 | int:MIR98 | |
| Interaction | MIR451A interactions | 2.16e-04 | 78 | 76 | 4 | int:MIR451A | |
| Interaction | RECQL4 interactions | LUC7L HBS1L IGF2BP1 IGF2BP3 IGF2BP2 NRDC CLPB SUPT5H MTHFD1L SPTLC1 MRPS11 RFC1 PPIH SBSN HNRNPK | 2.18e-04 | 1412 | 76 | 15 | int:RECQL4 |
| Interaction | MIR222 interactions | 2.26e-04 | 79 | 76 | 4 | int:MIR222 | |
| Interaction | MIR206 interactions | 2.26e-04 | 79 | 76 | 4 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 2.26e-04 | 79 | 76 | 4 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 2.26e-04 | 79 | 76 | 4 | int:MIR34C | |
| Interaction | POLN interactions | 2.36e-04 | 32 | 76 | 3 | int:POLN | |
| Interaction | MIR143 interactions | 2.38e-04 | 80 | 76 | 4 | int:MIR143 | |
| Interaction | MIR145 interactions | 2.49e-04 | 81 | 76 | 4 | int:MIR145 | |
| Interaction | MIR10B interactions | 2.61e-04 | 82 | 76 | 4 | int:MIR10B | |
| Interaction | MIR106A interactions | 2.74e-04 | 83 | 76 | 4 | int:MIR106A | |
| Interaction | MRPS26 interactions | 2.82e-04 | 448 | 76 | 8 | int:MRPS26 | |
| Interaction | MIR31 interactions | 2.87e-04 | 84 | 76 | 4 | int:MIR31 | |
| Interaction | MIR7-2 interactions | 2.87e-04 | 84 | 76 | 4 | int:MIR7-2 | |
| Interaction | MIR199A1 interactions | 2.87e-04 | 84 | 76 | 4 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 2.87e-04 | 84 | 76 | 4 | int:MIR200B | |
| Interaction | SNRNP70 interactions | LUC7L IGF2BP1 IGF2BP3 IGF2BP2 CLPB FANCI MRPS11 RFC1 PPIH THOC2 SNRPG HNRNPK | 2.97e-04 | 984 | 76 | 12 | int:SNRNP70 |
| Interaction | MIR107 interactions | 3.00e-04 | 85 | 76 | 4 | int:MIR107 | |
| Interaction | MIR17 interactions | 3.00e-04 | 85 | 76 | 4 | int:MIR17 | |
| Interaction | MIR18B interactions | 3.00e-04 | 85 | 76 | 4 | int:MIR18B | |
| Interaction | MIR93 interactions | 3.00e-04 | 85 | 76 | 4 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 3.00e-04 | 85 | 76 | 4 | int:MIR9-1 | |
| Interaction | MIR16-2 interactions | 3.00e-04 | 85 | 76 | 4 | int:MIR16-2 | |
| Interaction | USP50 interactions | 3.09e-04 | 35 | 76 | 3 | int:USP50 | |
| Interaction | KTI12 interactions | 3.09e-04 | 35 | 76 | 3 | int:KTI12 | |
| Interaction | MIR20B interactions | 3.14e-04 | 86 | 76 | 4 | int:MIR20B | |
| Interaction | CLEC14A interactions | 3.14e-04 | 86 | 76 | 4 | int:CLEC14A | |
| Interaction | HTATSF1 interactions | 3.19e-04 | 157 | 76 | 5 | int:HTATSF1 | |
| Interaction | CHEK1 interactions | 3.26e-04 | 245 | 76 | 6 | int:CHEK1 | |
| Interaction | PTCD3 interactions | 3.28e-04 | 346 | 76 | 7 | int:PTCD3 | |
| Interaction | MIR29A interactions | 3.28e-04 | 87 | 76 | 4 | int:MIR29A | |
| Interaction | TOP3B interactions | FOCAD TDRKH IGF2BP1 IGF2BP2 HIVEP2 IGF2R IMPDH1 CELSR3 VWA8 MTHFD1L FANCI NAV1 HERC1 THOC2 ZZEF1 | 3.37e-04 | 1470 | 76 | 15 | int:TOP3B |
| Interaction | MIR141 interactions | 3.43e-04 | 88 | 76 | 4 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 3.43e-04 | 88 | 76 | 4 | int:MIR138-2 | |
| Interaction | TRUB2 interactions | 3.51e-04 | 350 | 76 | 7 | int:TRUB2 | |
| Interaction | MIR29C interactions | 3.58e-04 | 89 | 76 | 4 | int:MIR29C | |
| Interaction | MIR221 interactions | 3.73e-04 | 90 | 76 | 4 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 3.73e-04 | 90 | 76 | 4 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 3.73e-04 | 90 | 76 | 4 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 3.89e-04 | 91 | 76 | 4 | int:MIR200C | |
| Interaction | MIR155 interactions | 4.06e-04 | 92 | 76 | 4 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 4.06e-04 | 92 | 76 | 4 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 4.23e-04 | 93 | 76 | 4 | int:MIR214 | |
| Interaction | MIR205 interactions | 4.23e-04 | 93 | 76 | 4 | int:MIR205 | |
| Interaction | C8orf82 interactions | 4.35e-04 | 168 | 76 | 5 | int:C8orf82 | |
| Interaction | MIR19B2 interactions | 4.40e-04 | 94 | 76 | 4 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 4.40e-04 | 94 | 76 | 4 | int:MIRLET7F1 | |
| Interaction | MIRLET7A2 interactions | 4.77e-04 | 96 | 76 | 4 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 4.96e-04 | 97 | 76 | 4 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 4.96e-04 | 97 | 76 | 4 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 4.96e-04 | 97 | 76 | 4 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 4.96e-04 | 97 | 76 | 4 | int:MIR363 | |
| Interaction | ART1 interactions | 4.97e-04 | 9 | 76 | 2 | int:ART1 | |
| Interaction | MIR106B interactions | 5.16e-04 | 98 | 76 | 4 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 5.36e-04 | 99 | 76 | 4 | int:MIR128-2 | |
| Interaction | DUSP1 interactions | 5.36e-04 | 99 | 76 | 4 | int:DUSP1 | |
| Interaction | MIR19A interactions | 5.57e-04 | 100 | 76 | 4 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 5.78e-04 | 101 | 76 | 4 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 5.78e-04 | 101 | 76 | 4 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 5.78e-04 | 101 | 76 | 4 | int:MIR25 | |
| Interaction | FLT1 interactions | 5.80e-04 | 179 | 76 | 5 | int:FLT1 | |
| Interaction | MIRLET7A3 interactions | 6.00e-04 | 102 | 76 | 4 | int:MIRLET7A3 | |
| Interaction | IMMP2L interactions | 6.10e-04 | 384 | 76 | 7 | int:IMMP2L | |
| Interaction | IGSF9 interactions | 6.19e-04 | 10 | 76 | 2 | int:IGSF9 | |
| Interaction | MIR15B interactions | 6.23e-04 | 103 | 76 | 4 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 6.23e-04 | 103 | 76 | 4 | int:MIR7-1 | |
| Interaction | FBXO32 interactions | 6.29e-04 | 386 | 76 | 7 | int:FBXO32 | |
| Interaction | MIR19B1 interactions | 6.46e-04 | 104 | 76 | 4 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 6.46e-04 | 104 | 76 | 4 | int:MIR34A | |
| Interaction | EP300 interactions | LUC7L HBS1L IGF2BP1 IGF2R ATR NRDC BRCA2 CLPB SUPT5H ZNF350 HERC1 PALS2 HNRNPK CHUK | 6.75e-04 | 1401 | 76 | 14 | int:EP300 |
| Interaction | MIRLET7E interactions | 6.94e-04 | 106 | 76 | 4 | int:MIRLET7E | |
| Interaction | AURKAIP1 interactions | 7.11e-04 | 284 | 76 | 6 | int:AURKAIP1 | |
| Interaction | CEBPA interactions | MPP2 IGF2BP1 GTF2F2 IGF2BP3 IGF2BP2 INTS7 FANCI RFC1 PPIH THOC2 SNRPG HNRNPK CCDC7 | 7.16e-04 | 1245 | 76 | 13 | int:CEBPA |
| Cytoband | 1q32.3 | 1.02e-03 | 28 | 77 | 2 | 1q32.3 | |
| GeneFamily | PDZ domain containing | 3.28e-05 | 152 | 44 | 5 | 1220 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.07e-03 | 20 | 44 | 2 | 548 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.81e-03 | 26 | 44 | 2 | 904 | |
| GeneFamily | Ankyrin repeat domain containing | 2.79e-03 | 242 | 44 | 4 | 403 | |
| GeneFamily | AAA ATPases | 7.37e-03 | 53 | 44 | 2 | 413 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 2.54e-05 | 197 | 77 | 6 | M8271 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 2.69e-05 | 199 | 77 | 6 | M6837 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN | 2.77e-05 | 200 | 77 | 6 | M4027 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN | 2.77e-05 | 200 | 77 | 6 | M6201 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GTF2F2 IGF2BP3 HIVEP2 IGF2R ATR BRCA2 MTR TNKS PALS2 THOC2 ZZEF1 | 3.95e-05 | 856 | 77 | 11 | M4500 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | IGF2BP3 ZNF600 IGF2BP2 IMPDH1 CELSR3 ATR BRCA2 MTHFD1L RFC1 THOC2 | 4.85e-05 | 721 | 77 | 10 | M10237 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.65e-05 | 91 | 74 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_500 | 1.79e-05 | 15 | 74 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TDRKH ZNF600 ERCC6 ATR BRCA2 FANCI MTR CCDC25 ALS2 HERC1 RIMS2 CHUK | 2.46e-05 | 820 | 74 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | TDRKH IGF2BP1 ZNF600 ERCC6 ATR BRCA2 INTS7 FANCI MTR ALS2 RIMS2 CA8 | 2.52e-05 | 822 | 74 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.54e-07 | 182 | 77 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 177 | 77 | 5 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.48e-05 | 179 | 77 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-05 | 181 | 77 | 5 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 183 | 77 | 5 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.73e-05 | 185 | 77 | 5 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-05 | 186 | 77 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-05 | 188 | 77 | 5 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-05 | 189 | 77 | 5 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.98e-05 | 92 | 77 | 4 | d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.98e-05 | 92 | 77 | 4 | 926e02725a03d8473eda25d4aef63e34a6566224 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 2.02e-05 | 191 | 77 | 5 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.12e-05 | 193 | 77 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.12e-05 | 193 | 77 | 5 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.34e-05 | 197 | 77 | 5 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 101 | 77 | 4 | af4a84e4993d4e80c834e1591556b3b3781deaf3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.26e-04 | 148 | 77 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.74e-04 | 161 | 77 | 4 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | BL-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.79e-04 | 162 | 77 | 4 | 25ec9df914445b4daae4fd28fd0e60b64797c46d | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 167 | 77 | 4 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 168 | 77 | 4 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 168 | 77 | 4 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 169 | 77 | 4 | d382a76d85875663502cc7dde2e3e0682605768e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 169 | 77 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 170 | 77 | 4 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 170 | 77 | 4 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-04 | 172 | 77 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-04 | 173 | 77 | 4 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 173 | 77 | 4 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 173 | 77 | 4 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 173 | 77 | 4 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-04 | 173 | 77 | 4 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-04 | 174 | 77 | 4 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-04 | 176 | 77 | 4 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-04 | 176 | 77 | 4 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-04 | 176 | 77 | 4 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 178 | 77 | 4 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 179 | 77 | 4 | 142457c98656ed389461e081e0e6d03e86d2fb1a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-04 | 180 | 77 | 4 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 181 | 77 | 4 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 181 | 77 | 4 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 181 | 77 | 4 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-04 | 182 | 77 | 4 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | b1c1bb1b80c65dea2558051fd5953c1c4a251c1e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.78e-04 | 182 | 77 | 4 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-04 | 182 | 77 | 4 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 182 | 77 | 4 | 8b16a13d8606d21a7a9ce1175237e9b4cf832ee0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-04 | 183 | 77 | 4 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-04 | 183 | 77 | 4 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 183 | 77 | 4 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-04 | 183 | 77 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 183 | 77 | 4 | 29defb21458bc43d22ca5e4d08218db45aaa1add | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-04 | 183 | 77 | 4 | 302bd0f1f8025f385a764f2a9adafdd7f1f67ea3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 184 | 77 | 4 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 184 | 77 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 184 | 77 | 4 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 184 | 77 | 4 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.96e-04 | 185 | 77 | 4 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.96e-04 | 185 | 77 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 185 | 77 | 4 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.96e-04 | 185 | 77 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 185 | 77 | 4 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-04 | 185 | 77 | 4 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-04 | 186 | 77 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-04 | 186 | 77 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-04 | 186 | 77 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-04 | 187 | 77 | 4 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.09e-04 | 187 | 77 | 4 | fae08f34dc4b15352bd4d10bc6c924fe119b5d5e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.09e-04 | 187 | 77 | 4 | e6b140b9fb582abf07aa6ea9bc437de3ba0d6de1 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.09e-04 | 187 | 77 | 4 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.09e-04 | 187 | 77 | 4 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-04 | 188 | 77 | 4 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-04 | 188 | 77 | 4 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 3.15e-04 | 188 | 77 | 4 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.15e-04 | 188 | 77 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 188 | 77 | 4 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 188 | 77 | 4 | e079a3873cf442e98ff41a240c80b80995aace11 | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 188 | 77 | 4 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-04 | 188 | 77 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.15e-04 | 188 | 77 | 4 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 189 | 77 | 4 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 3.21e-04 | 189 | 77 | 4 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 189 | 77 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 189 | 77 | 4 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-04 | 189 | 77 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.21e-04 | 189 | 77 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-04 | 189 | 77 | 4 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.21e-04 | 189 | 77 | 4 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 190 | 77 | 4 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 190 | 77 | 4 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-04 | 190 | 77 | 4 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 190 | 77 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 3.28e-04 | 190 | 77 | 4 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 190 | 77 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 190 | 77 | 4 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 190 | 77 | 4 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 190 | 77 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 6.30e-08 | 4 | 75 | 3 | DOID:0060158 (implicated_via_orthology) | |
| Disease | medial orbital frontal cortex volume measurement | 3.48e-05 | 25 | 75 | 3 | EFO_0010315 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.38e-05 | 152 | 75 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 5.50e-05 | 29 | 75 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 6.09e-05 | 30 | 75 | 3 | C0029925 | |
| Disease | spine bone mineral density change measurement, response to combination chemotherapy | 6.34e-05 | 5 | 75 | 2 | EFO_0007965, EFO_0008474 | |
| Disease | neuropilin-1 measurement | 1.33e-04 | 7 | 75 | 2 | EFO_0020603 | |
| Disease | colorectal health | 1.64e-04 | 201 | 75 | 5 | EFO_0008460 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.77e-04 | 8 | 75 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 1.77e-04 | 8 | 75 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | coronary artery disease | NELL1 TDRKH HBS1L IGF2BP1 IGF2BP2 HIVEP2 IGF2R MTHFD1L UNC13D TNKS NRP1 | 2.07e-04 | 1194 | 75 | 11 | EFO_0001645 |
| Disease | Tetralogy of Fallot | 2.83e-04 | 10 | 75 | 2 | HP_0001636 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.83e-04 | 10 | 75 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | biological sex | 3.05e-04 | 230 | 75 | 5 | PATO_0000047 | |
| Disease | placenta growth factor measurement | 3.45e-04 | 11 | 75 | 2 | EFO_0010626 | |
| Disease | phenylacetate measurement | 4.14e-04 | 12 | 75 | 2 | EFO_0021012 | |
| Disease | survival time, lung adenocarcinoma | 4.14e-04 | 12 | 75 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | disease progression measurement | 5.11e-04 | 61 | 75 | 3 | EFO_0008336 | |
| Disease | nephroblastoma (is_implicated_in) | 5.69e-04 | 14 | 75 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Fanconi anemia | 5.69e-04 | 14 | 75 | 2 | cv:C0015625 | |
| Disease | obstructive sleep apnea | 6.43e-04 | 66 | 75 | 3 | EFO_0003918 | |
| Disease | schizophrenia (implicated_via_orthology) | 7.02e-04 | 68 | 75 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Leber congenital amaurosis | 7.48e-04 | 16 | 75 | 2 | cv:C0339527 | |
| Disease | Schizoaffective disorder-bipolar type | 7.48e-04 | 16 | 75 | 2 | EFO_0009965 | |
| Disease | Age-related macular degeneration | 9.50e-04 | 18 | 75 | 2 | cv:C0242383 | |
| Disease | Bone marrow hypocellularity | 9.50e-04 | 18 | 75 | 2 | C1855710 | |
| Disease | cardiovascular disease | 1.09e-03 | 457 | 75 | 6 | EFO_0000319 | |
| Disease | small cell lung carcinoma | 1.13e-03 | 80 | 75 | 3 | EFO_0000702 | |
| Disease | number of teeth measurement | 1.18e-03 | 20 | 75 | 2 | EFO_0010073 | |
| Disease | reticulocyte count | 1.31e-03 | 1045 | 75 | 9 | EFO_0007986 | |
| Disease | Leber Congenital Amaurosis | 1.42e-03 | 22 | 75 | 2 | C0339527 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.53e-03 | 194 | 75 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | Carcinoma of lung | 1.56e-03 | 23 | 75 | 2 | C0684249 | |
| Disease | pallidum volume | 1.84e-03 | 25 | 75 | 2 | EFO_0006933 | |
| Disease | erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, hematocrit, obsolete_red blood cell distribution width, mean corpuscular hemoglobin | 1.84e-03 | 25 | 75 | 2 | EFO_0004305, EFO_0004348, EFO_0004526, EFO_0004527, EFO_0004528, EFO_0005192 | |
| Disease | Fanconi Anemia | 1.84e-03 | 25 | 75 | 2 | C0015625 | |
| Disease | breast cancer (implicated_via_orthology) | 1.84e-03 | 25 | 75 | 2 | DOID:1612 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 1.85e-03 | 507 | 75 | 6 | C2239176 | |
| Disease | lobe attachment | 1.94e-03 | 207 | 75 | 4 | EFO_0007667 | |
| Disease | Pancytopenia | 1.99e-03 | 26 | 75 | 2 | C0030312 | |
| Disease | Miller Dieker syndrome | 2.48e-03 | 29 | 75 | 2 | C0265219 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQHGNHITLELIKGK | 226 | Q9BZ76 | |
| LLNVEGVKKTILHGG | 6 | Q9NZN9 | |
| RGGHLVILKQLLNQG | 186 | Q86SG2 | |
| LKGVNGKDIIKHLIN | 1096 | Q96M83 | |
| GIIKGSINAQLKGHQ | 1131 | Q96M83 | |
| GIAKGNVALKIHNIQ | 101 | Q9UIR0 | |
| KTVLQAALGVKHGVL | 41 | Q96Q42 | |
| DLIVVLHNGKIKEQG | 1221 | Q2M3G0 | |
| VNLDGKKILVVGAHG | 216 | Q6UB35 | |
| KQKHLQAILGGAEVK | 191 | Q03468 | |
| LLGQQKIKHPIVGDV | 346 | Q8IUZ5 | |
| GKHVVFGKIIDGLLV | 136 | O43447 | |
| EILQLLKGKLVVGHD | 76 | Q96AZ6 | |
| QLALKVEGVVQHGSK | 826 | Q9NVH2 | |
| GGKQLLNLVVIGHVD | 256 | Q9Y450 | |
| KQKHLQAILGGAEVK | 191 | P0DP91 | |
| GRELVKHLKVGQQGD | 286 | Q9NVI1 | |
| VICHQLQLGGKGIAK | 206 | P56730 | |
| GGKLHLGFIQIREKL | 211 | Q9NQ29 | |
| AVGAIIGKKGQHIKQ | 416 | Q9NZI8 | |
| VLQDVGGKIIHKIID | 151 | O15111 | |
| VHGLLEDQFGGKIKQ | 2601 | Q15751 | |
| LEGLLQKAVEKGAVH | 361 | A0A0J9YX94 | |
| LHIEQGKIGVVFNIG | 1146 | Q9Y4C0 | |
| GLLHVGDIIKEVNGQ | 201 | Q14168 | |
| TQAVGAIIGKKGAHI | 436 | Q9Y6M1 | |
| VGQIGFHRQKDVKIV | 106 | Q86WR0 | |
| SVGAIIGKQGQHIKQ | 416 | O00425 | |
| KHGLFKGIIQDGKII | 196 | Q92832 | |
| GPKHLKVQVGQRVDI | 1176 | Q96RW7 | |
| GIQTVGHVVKALALG | 366 | P20839 | |
| DKVGHQLIVTILGAK | 816 | Q9UQ26 | |
| EEKIVRGIIIQGGKH | 491 | O14786 | |
| RGIIIQGGKHRENKV | 496 | O14786 | |
| QGLLHVGDIIKEVNG | 166 | Q9NZW5 | |
| KGDVHQALIVLQKGV | 1966 | Q13535 | |
| KNGRLTVGQKIILHG | 2741 | P51587 | |
| IALFVQIGKEHVGLK | 166 | P35219 | |
| VGHEEGGQLTKKLKQ | 431 | Q9H078 | |
| IAKGVGTQKIIGRVH | 281 | Q5TDH0 | |
| ELQGLKVKQLHVGGL | 1886 | Q9NYQ7 | |
| QALTEIGQKHGLVGL | 151 | Q3KQZ1 | |
| INHGIGQAGKEAEKL | 101 | Q6UWP8 | |
| GQHGNHITLELIKGK | 226 | Q96NU0 | |
| QGRLGELELQLKHGK | 906 | Q5VW36 | |
| LKKGIIGGVKVHVDR | 641 | Q93100 | |
| LKVHQIKGTVLIGVN | 856 | Q5VU65 | |
| LQEGAKDGIKVHGQK | 1771 | Q8NEY1 | |
| VNNGLKVEKGHSEII | 1311 | P0C091 | |
| VLGLVHTQKLGVIGD | 2056 | P11717 | |
| ILKEIGVQNVKGIHK | 216 | P13984 | |
| EVNVLIGRGQGKKNH | 186 | Q8WXG1 | |
| GKIGVKVFLVNIHAQ | 691 | Q7LBE3 | |
| VKLNLLITGKIVDHG | 131 | P58417 | |
| RGGIQELIGLIKHTK | 731 | P35251 | |
| LHIEQGKIGVVFNIG | 141 | Q9HDB5 | |
| SIIGKGGQRIKQIRH | 401 | P61978 | |
| EGLGIHTGVNLQKLL | 286 | P35914 | |
| KGDVHDIGKNIVGVV | 781 | Q99707 | |
| KDIIHVVKDQLIGQG | 41 | Q8NEK8 | |
| GQLKVGHVILEVNGL | 856 | Q9P202 | |
| KQTHVKQAIEGVGNL | 231 | O00267 | |
| VHGIIKNGGVKPNII | 251 | Q8IYS1 | |
| GQIHKALQGISGLKV | 371 | O15269 | |
| EQVSKLAGVLVKHGI | 151 | Q9H6R3 | |
| QKGVIHIRVVVKGLG | 141 | P82912 | |
| NGVIFQEGGEKHLKL | 751 | Q8NI27 | |
| NGKKLDIGLELVHKG | 476 | Q9Y2W6 | |
| KLSLKLNGGRHVQGI | 16 | P62308 | |
| IEVNGVNVVKVGHKQ | 631 | Q9BYB0 | |
| TILQVLGHVAKAGLG | 96 | Q96BH1 | |
| IKGKIDVCIVLLQHG | 291 | O95271 | |
| KLVAGEHGLIIRVKG | 751 | O43847 | |
| GVIHGLGKVLEIQKN | 1256 | Q8WWQ8 | |
| GKGFIQKGNLIVHQR | 296 | Q9GZX5 | |
| QEVHLKIGIGPQRGK | 131 | Q08ER8 | |
| HQGKGLKALALLGVL | 1951 | O43149 | |
| NVHVLGVLLGQKEGK | 736 | Q6PGP7 | |
| HLLLVGNQGVGKNKI | 776 | A3KMH1 | |
| LVGNILKERGKGDIH | 1746 | P31629 | |
| PELHIIQIKGKIGNQ | 96 | Q6ZNG1 | |
| QLEVGIAKHIQKLVG | 766 | Q70J99 |